Skip to content

AGES hysteroscopy-IVF trial

Effects of routine hysteroscopy on the reproductive outcomes in women undergoing IVF cycle: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201905470796922
Enrollment
770
Registered
2019-05-15
Start date
2019-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

Hysteroscopy group

Sponsors

LIFE SPECIALIST HOSPITAL
Lead Sponsor
Gynescope specialist hospital
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All consenting infertile women, scheduled to start IVF or ICSI treatment. Women having a normal transvaginal ultrasound of the uterine cavity (defined as no visible intracavitary pathology—eg, submucous myomas, polyps, or septa).

Exclusion criteria

Exclusion criteria: Women who will be planning cycles of preimplantation genetic testing. Women with a diagnosis of a congenital or acquired uterine abnormality (such as a uterine malformation, adenomyosis, submucous myoma, or intrauterine adhesion). Women with medical conditions that are contraindications to IVF procedures or pregnancy, such as uncontrolled hypertension, known symptomatic heart disease, poorly controlled type 1 or type 2 diabetes, undiagnosed liver disease or dysfunction, renal disease, severe anaemia, history of deep venous thrombosis, history of pulmonary embolus, previous cerebrovascular accident, or history of cervical cancer, endometrial cancer, or breast cancer. Women who will be planning to undergo frozen embryo transfer. Women with poor ovarian reserve using FSH of >9iu.

Design outcomes

Primary

MeasureTime frame
proportion with a clinically recognized pregnancy ;live birth rate

Secondary

MeasureTime frame
chemical pregnancy rate;miscarriage rate;ectopic pregnancy rate;procedure (hysteroscopy) related complications

Countries

Nigeria

Contacts

Public ContactALABI OLAJUWON

CONSULTANT

christianalabi@gmail.com+2348056875395

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026